Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study Study of Daxdilimab(HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Ext ...
An Open-Label Extension Study To Evaluate The Long- Term Safety And Tolerability Of Daxdilimab (Hzn-7734) In Subjects With Systemic Lupus Erythematosus An Open-Label Extension Study To Evaluate The Long- Term Safety And Tolerability Of Daxdilimab(Hzn-7 ...